NOX Complex: A Drug Target and Biomarker for Diseases (P24924)

Target Name: NADPH Oxidase Complex

NCBI ID: P24924

NADPH Oxidase Complex

Other Name(s): NOX complex

NOX Complex: A Drug Target and Biomarker for Diseases

The NADPH Oxidase Complex (NOX complex) is a protein complex that plays a crucial role in the production of NADPH, a crucial co-factor for many cellular processes. NADPH is a molecule that is involved in the transfer of electrons during the process of redox reactions, and it is essential for the maintenance of cellular homeostasis and the production of energy. The NOX complex is a multi-subunit protein complex that is composed of four subunits: NOX1, NOX2, NOX3, and NOX4. This complex is located in the cytosol of eukaryotic cells and is responsible for the production of NADPH from NADP+ and H2O.

The NOX complex is a well-established drug target and has been identified as a potential therapeutic target for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The discovery of the NOX complex as a drug target has led to the development of small molecule inhibitors that can inhibit the activity of the NOX complex and prevent the production of NADPH. These inhibitors have been shown to have therapeutic potential in preclinical studies for treating a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The NOX complex is also a potential biomarker for a variety of diseases. The production of NADPH by the NOX complex is a critical step in the production of NADPH, which is then used to participate in a variety of cellular processes, including the production of reactive oxygen species (ROS), such as superoxide and hydrogen peroxide. The levels of NADPH and the production of ROS are sensitive to a variety of factors, including pH, temperature, and the availability of oxygen. Therefore, the NOX complex can be used as a biomarker for a variety of diseases, including oxidative stress-related disorders, such as cancer, neurodegenerative diseases, and autoimmune disorders.

The NOX complex is also involved in the regulation of cellular homeostasis. NADPH is a crucial co-factor for the production of many cellular processes, including the production of signaling molecules, such as P21 and PDGF-A. NADPH also plays a role in the production of other molecules that are involved in cellular signaling, such as neurotransmitters and cytokines. The levels of NADPH are regulated by a variety of factors, including the availability of oxygen and the levels of NADP+ in the cytosol. Therefore, the NOX complex can also be used as a biomarker for cellular homeostasis and the regulation of cellular signaling.

In conclusion, the NADPH Oxidase Complex (NOX complex) is a protein complex that is involved in the production of NADPH from NADP+ and H2O. The NOX complex is a well-established drug target and has been identified as a potential therapeutic target for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The NOX complex is also a potential biomarker for a variety of diseases, including oxidative stress-related disorders, the regulation of cellular homeostasis, and the production of cellular signaling molecules. The development of small molecule inhibitors that can inhibit the activity of the NOX complex has shown promise in preclinical studies for treating a variety of diseases. Further research is needed to fully understand the role of the NOX complex as a drug target and biomarker, and to develop effective therapies for the treatment of a variety of diseases.

Protein Name: NADPH Oxidase Complex

The "NADPH Oxidase Complex Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NADPH Oxidase Complex comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets